Postoperative Pericardial Flush, to evaluate the effects of pericardial flush with a crystalloid on blood loss after CABG.

Completed

• Conditions: blood loss; transfusion requirements; 10007593

• Registration Number: NL-OMON44986
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 180

Inclusion Criteria

- All adult patients (>18y) undergoing surgery for CABG.

Exclusion Criteria

- Previous CABG;
- Emergency surgery;
- Preoperative use of Dabigatran, Rivaroxaban, Apixaban, Clopidogrel, Brilique or Prasugrel;
- Participation in any study involving an investigational drug or device;
- Age <18 years and/or inability to understand study information / give informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>To determine whether postoperative pericardial flush with a crystalloid can<br /><br>reduce postoperative blood loss by effectively removing contaminated<br /><br>pericardial blood after CABG. The primary study endpoints include: blood loss<br /><br>12h postoperative and delta haemoglobin (between sternal closure and 12h<br /><br>postoperative).</p><br>